During the last few decades, pediatric acute lymphoblastic leukemia (ALL) cure rates have
improved significantly with rates exceeding 90%. Parallel to this remarkable improvement …

Purpose Acute lymphoblastic leukemia (ALL) survivors are the largest group of childhood
cancer survivors; however, their risk for late effects is high. Cancer-related late effects have …

Importance In light of the excellent long-term survival of childhood cancer patients, it is
imperative to screen for factors affecting health, function, and quality of life in long-term …

Simple Summary Around 80% of children treated for childhood cancer become long-term
survivors. Although chemotherapy and radiotherapy improve survival of these patients, they …

Background Acute lymphoblastic leukaemia (ALL) is the most common paediatric
malignancy in the world. Advances in treatment protocols have resulted in survival rates of> …

Glucocorticoids (GCs) are widely used in the treatment of childhood acute lymphoblastic
leukemia (ALL), but their long-term use is also associated with bone-related morbidities …

Endocrine late effects have been reported in up to 50% of childhood cancer survivors
(CCS)> 5 years after treatment. 1–4 Most endocrine disorders are amenable to treatment; …

Childhood cancer survivor (CCS) numbers are increasing as a result of advances in both
treatment and supportive care. This positive outcome is tempered by the recognition of a …

Background: With improved long-term health outcomes and survivorship, the long-term
nutritional management of childhood cancer survivors, from diagnosis to long-term follow …

Few studies so far have examined the impact of nutritional status on the survival of children
with cancer, with the majority of them focusing on hematological malignancies. We …